As of Feb 12
| +1.12 / +4.38%|
The 4 analysts offering 12-month price forecasts for Enanta Pharmaceuticals Inc have a median target of 28.50, with a high estimate of 38.00 and a low estimate of 18.00. The median estimate represents a +6.74% increase from the last price of 26.70.
The current consensus among 4 polled investment analysts is to Buy stock in Enanta Pharmaceuticals Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.